Corient Private Wealth
ADPT icon

Corient Private Wealth’s Adaptive Biotechnologies ADPT Stock Holding History

Corient Private Wealth’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1,000K Sell
72,201
-71,615
-50% -$1.14M ﹤0.01% 1665
2025
Q4 		$2.34M Buy
143,816
+74,255
+107% +$1.21M ﹤0.01% 1445
2025
Q3 		$1.04M Sell
69,561
-5,835
-8% -$71.1K ﹤0.01% 1409
2025
Q2 		$878K Sell
75,396
-1,441
-2% -$13.1K ﹤0.01% 1425
2025
Q1 		$571K Sell
76,837
-10,811
-12% -$83.1K ﹤0.01% 1538
2024
Q4 		$525K Buy
87,648
+643
+0.7% +$3.54K ﹤0.01% 1589
2024
Q3 		$445K Buy
87,005
+5,261
+6% +$22.9K ﹤0.01% 1802
2024
Q2 		$296K Buy
81,744
+2,043
+3% +$6.49K ﹤0.01% 1928
2024
Q1 		$256K Sell
79,701
-3,223
-4% -$12.5K ﹤0.01% 1980
2023
Q4 		$406K Sell
82,924
-47,093
-36% -$215K ﹤0.01% 1719
2023
Q3 		$709K Sell
130,017
-10,774
-8% -$71.2K ﹤0.01% 1316
2023
Q2 		$945K Buy
140,791
+67,288
+92% +$500K ﹤0.01% 1180
2023
Q1 		$649K Buy
73,503
+1,383
+2% +$12.2K ﹤0.01% 1269
2022
Q4 		$551K Buy
+72,120
New +$561K ﹤0.01% 1108

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Corient Private Wealth's ADPT Position: Q1 2026 in Review

Corient Private Wealth reduced its Adaptive Biotechnologies (ADPT) stake by 50% in Q1 2026, selling an estimated $1.14M and leaving 72,201 shares worth $1,000K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Corient Private Wealth first reported a position in ADPT in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.34M in Q4 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Corient Private Wealth held 72,201 shares of Adaptive Biotechnologies worth $1,000K as of Q1 2026.
  • Corient Private Wealth sold 71,615 Adaptive Biotechnologies shares in Q1 2026, an estimated $1.14M.
  • Adaptive Biotechnologies made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1665 holding.
  • Corient Private Wealth first reported a position in Adaptive Biotechnologies in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Adaptive Biotechnologies position peaked at $2.34M in Q4 2025.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.